Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Chitosan-decorated nanoparticles can improve skin delivery and reduce side effects of finasteride.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Poria cocos polysaccharides and finasteride both help treat chronic nonbacterial prostatitis, but Poria cocos polysaccharides also improve gut health.

Accidental findings have led to new hair treatment discoveries, like using blood pressure and diabetes medications for hair loss and unwanted hair.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Finasteride for hair loss has minimal impact on sexual function.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Physical activity, height, and smoking affect prostate cancer risk.

KGF and its receptor are found in enlarged prostate tissue and KGF strongly increases cell growth.

Finasteride reduces blood loss and the need for blood transfusions during and after TURP surgery.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

New compounds may help treat prostate cancer by reducing cell growth.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Finasteride's effects on prostate cancer are not clear from this text.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.